HealthSignals Secures Telehealth Agreement with Premier
Committed to enhancing the quality of care, HealthSignals provides facilities with essential tools that prioritize security, reliability, and effective communication and collaboration for telehealth and telemedicine applications.
Global Pharma | 18/04/2024 | By Manvi | 394
X-Therma's XT-Thrive Receives FDA Acceptance for Key Drug Master File
This milestone covers the Chemistry, Manufacturing, and Controls (CMC) for XT-Thrive®, a revolutionary cryopreservation solution enabling non-toxic preservation for life-saving regenerative medicines.
Global Pharma | 18/04/2024 | By Abha | 590
Recce Pharmaceuticals Hits Milestone with RECCE 327 Batch Completion Under GMP
The company's lead candidate, R327, marks a new era in synthetic anti-infectives, with the patented manufacturing process now yielding 5,000 GMP doses per week.
Global Pharma | 18/04/2024 | By Abha | 371
Emerson Introduces DeltaV Workflow Management to Simplify Pharmaceutical Development
Emerson has released DeltaV Workflow Management, a next-generation software designed for life sciences companies in early-stage development.
Global Pharma | 18/04/2024 | By Aishwarya | 1075
Merck Unveils First All-in-One Genetic Stability Assay to Boost Biosafety Testing
Merck has unveiled the first all-in-one, validated genetic stability assay of its kind.
Global Pharma | 18/04/2024 | By Aishwarya | 577
Telomir Pharmaceuticals Launches Pre-Clinical Data on Age-Reversal Drug Telomir-1
Telomir Pharmaceuticals, Inc. has summarized its presentation of compelling pre-clinical data on Telomir-1 at a high-profile event.
Global Pharma | 18/04/2024 | By Aishwarya | 1476
The financing advances Evergreen's novel discovery pipeline into clinical trials, supports commercialization of its diagnostic agent, and further expands CDMO capabilities to meet growing client demand.
Global Pharma | 16/04/2024 | By Manvi | 766
Sarasota Memorial Healthcare Raises Over USD 93 Mn to Support Cancer Care at SMH
At the time, 50% of cancer patients were leaving the community for treatment. With a belief that no one should have to leave home for the best cancer care, a plan was developed to create a world-class cancer institute with comprehensive, quality-driven, patient-centered care.
Global Pharma | 16/04/2024 | By Manvi | 821
FDA Inaugurates CDER Center for Clinical Trial Innovation (C3TI)
FDA's Center for Drug Evaluation and Research (CDER) has launched the CDER Center for Clinical Trial Innovation (C3TI).
Global Pharma | 16/04/2024 | By Aishwarya | 605
Caplin Steriles Receives USFDA Approval for Generic Ofloxacin Ophthalmic Solution
This approval marks the introduction of a generic therapeutic equivalent version of OCUFLOX Ophthalmic Solution by Allergan Inc.
Global Pharma | 16/04/2024 | By Abha | 712
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy